CN Patent

CN118843488A — 用于递送芳香化酶抑制剂的植入式医疗器件

Assigned to Celanese EVA Performance Polymers LLC · Expires 2024-10-25 · 2y expired

What this patent protects

提供了一种植入式医疗器件。芯体包含芯体聚合物基质，在芯体聚合物基质中分散有包含一种或多种芳香化酶抑制剂的治疗剂。芯体聚合物基质包含乙烯‑乙酸乙烯酯共聚物。乙烯‑乙酸乙烯酯共聚物具有根据ASTM D3418‑15测定的约40℃至约120℃的熔融温度。

USPTO Abstract

提供了一种植入式医疗器件。芯体包含芯体聚合物基质，在芯体聚合物基质中分散有包含一种或多种芳香化酶抑制剂的治疗剂。芯体聚合物基质包含乙烯‑乙酸乙烯酯共聚物。乙烯‑乙酸乙烯酯共聚物具有根据ASTM D3418‑15测定的约40℃至约120℃的熔融温度。

Drugs covered by this patent

elacestrant-hydrochloride (ELACESTRANT HYDROCHLORIDE)

Patent Metadata

Patent number: CN118843488A
Jurisdiction: CN
Classification: —
Expires: 2024-10-25
Drug substance claim: No
Drug product claim: No
Assignee: Celanese EVA Performance Polymers LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.